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Collagenase-3 (MMP-13) Enhances Remodeling
of Three-Dimensional Collagen and Promotes
Survival of Human Skin Fibroblasts
Mervi J. Toriseva1,2,3,4, Risto Ala-aho1,2,3, Jarkko Karvinen5, Andrew H. Baker6, Varpu S. Marjoma¨ki7,
Jyrki Heino8 and Veli-Matti Ka¨ha¨ri1,2,3
Collagenase-3 (MMP-13) is a matrix metalloproteinase capable of cleaving a multitude of extracellular matrix
proteins in addition to fibrillar collagens. Human MMP-13 is expressed by fibroblasts in chronic cutaneous
ulcers, but not in normally healing adult skin wounds. However, MMP-13 is produced by fibroblasts in adult
gingival and in fetal skin wounds characterized by rapid collagen remodeling and scarless healing. Here, we
have examined the role of human MMP-13 in remodeling of three-dimensional (3D) collagenous matrix by
primary adult human skin fibroblasts. The high level of human MMP-13 expression by fibroblasts achieved by
adenoviral gene delivery resulted in potent enhancement of remodeling and contraction of 3D collagen.
Fibroblasts expressing MMP-13 in 3D collagen possessed altered filamentous actin morphology with patch-like
actin distribution in cell extensions. The expression of MMP-13 promotes survival and proliferation of
fibroblasts in floating collagen gel, and results in activation of Akt and extracellular signal-regulated kinase-1/2
by these cells. The results provide evidence for a novel role for human MMP-13 in regulating dermal fibroblast
survival, proliferation, and interaction in 3D collagen, which may be an important survival mechanism for
fibroblasts in chronic skin ulcers and contribute to scarless healing of adult gingival and fetal skin wounds.
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INTRODUCTION
Cutaneous wound repair is a complex physiological process
in which various growth factors and cytokines regulate the
overlapping phases of healing, that is, inflammation, re-epi-
thelialization, granulation tissue formation, matrix remodel-
ing, and wound contraction. Despite effective remodeling
of newly formed extracellular matrix (ECM), the end result
of wound healing in skin is usually a relatively acellular and
collagenous scar, which obtains about 70% of the original
tensile strength of intact skin (Singer and Clark, 1999). The
cells responsible for production of new collagenous dermal
ECM in wound are fibroblasts, which also remodel new
collagenous stroma by producing matrix degrading protein-
ases (Ravanti and Ka¨ha¨ri, 2000). Matrix metalloproteinases
(MMPs) are a family of zinc-dependent endopeptidases,
which as a group are capable of cleaving all ECM molecules
and numerous non-matrix substrates (Ravanti and Ka¨ha¨ri,
2000; Sternlicht and Werb, 2001). MMPs are involved in
several physiological and pathological events, such as
embryonal tissue development, angiogenesis, and cancer,
as well as in different phases of wound repair by stimulating
cell migration and activating growth factors, and other
proteinases (Ravanti and Ka¨ha¨ri, 2000; Sternlicht and Werb,
2001).
Fibrillar collagens of types I, II, and III are cleaved by
members of the collagenase subgroup of MMPs: collagenase-1
(MMP-1) (Goldberg et al., 1986), collagenase-2 (MMP-8)
(Hasty et al., 1990), and collagenase-3 (MMP-13) (Freije
et al., 1994). Also gelatinase-A (MMP-2) and membrane-type-
1 MMP (MMP-14) are capable of cleaving fibrillar collagens
(Aimes and Quigley, 1995; Ohuchi et al., 1997). After dermal
wounding, the expression of MMP-1 is temporarily induced
in migrating keratinocytes in response to contact with type I
collagen of dermis (Saarialho-Kere et al., 1992; Pilcher
et al., 1997). In addition, MMP-1 is produced by dermal
fibroblasts in normal and chronic wounds (Vaalamo et al.,
1997). Other MMPs, including stromelysin-1 (MMP-3),
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also produced in mammalian wounds by cells participating
in re-epithelialization, vascularization, and inflammation
(Vaalamo et al., 1999). Accordingly, inhibition of MMP
activity suppresses dermal wound healing in vivo (A˚gren
et al., 2001; Beare et al., 2003).
Collagenase-3 (MMP-13) can cleave a wide selection of
substrates, including fibrillar collagens and other ECM
components, as well as non-matrix components, such as
transforming growth factor-b (Fosang et al., 1996; Kna¨uper
et al., 1996; Ashworth et al., 1999; D’Angelo et al., 2001).
MMP-13 is characterized by limited physiological expression
pattern, and it is not expressed by any cells during normal
wound healing in adult human skin (Vaalamo et al., 1997).
However, MMP-13 is abundantly expressed by fibroblasts in
adult gingival wounds (Ravanti et al., 1999b) and fetal skin
wounds (Ravanti et al., 2001), which heal with minimal
scarring, suggesting a role for MMP-13 in effective remodel-
ing of collagenous granulation tissue resulting in scarless
wound repair. Moreover, the expression of MMP-13 by
fibroblasts in chronic dermal ulcers suggests a role for MMP-
13 in the pathogenesis of chronic ulcers (Vaalamo et al.,
1997).
Here, we have examined the role of MMP-13 in fibroblast-
mediated remodeling of three-dimensional (3D) collagenous
matrix in a floating collagen lattice, a widely used model for
dermal wound contraction and matrix reorganization by
fibroblasts (Bell et al., 1979). Our results show that adenoviral
expression of MMP-13 enhances collagen gel contraction by
HSFs and results in altered morphology of their actin-
containing extensions. Furthermore, expression of MMP-13
results in activation of Akt and ERK1/2 signaling pathways,
and inhibits apoptosis and stimulates proliferation of fibro-
blasts in 3D collagen. These results suggest a role for MMP-
13 in collagen remodeling and contraction by affecting cell
interaction with surrounding 3D matrix and increasing cell
number in collagen by promoting survival and proliferation.
RESULTS
MMP-13 enhances collagen gel contraction by skin fibroblasts
MMP-13 is not expressed in normally healing adult human
skin wounds (Vaalamo et al., 1997). However, it is produced
by fibroblasts in adult gingival wounds (Ravanti et al., 1999b)
and in fetal skin wounds (Ravanti et al., 2001), both
characterized by rapid healing with minimal scar formation
(Ha¨kkinen et al., 2000; Bullard et al., 2003), suggesting a role
for MMP-13 in effective remodeling of collagenous tissue
involved in scarless healing. To study in detail the role of
MMP-13 in fibroblast-mediated collagenous matrix remodel-
ing, we used adenoviral gene delivery to obtain high-level
expression of MMP-13 in primary adult human skin
fibroblasts (HSFs), which normally express MMP-13 at low
level only when cultured within 3D collagen (Ravanti et al.,
1999a). HSFs were transduced with adenovirus encoding
human MMP-13 (RAdMMP-13) or with empty control adeno-
virus (RAdpCA3) and subsequently cultured in floating type I
collagen gels for 4 days. Transduction with RAdMMP-13
resulted in marked dose-dependent production of proMMP-
13 protein by HSFs in collagen (Figure 1a). In comparison,
production of MMP-1, the expression of which is highly
stimulated in fibroblasts by ligation of a2b1-integrin with type
I collagen (Langholz et al., 1995), was not markedly altered
by RAdMMP-13-transduced HSFs (Figure 1a). Adenoviral
expression of MMP-13 resulted in marked and dose-
dependent increase in collagen gel contraction (by up to
60%), as compared to cultures transduced with control virus
RAdpCA3 (Figure 1b). Collagen gel contraction by RAdpCA3
and RAdMMP-13-transduced HSFs was first noted after
culturing for 24 hours in floating collagen gel and it
continued up to 4 days (data not shown).
In further experiments, the effect of exogenously added
recombinant human MMP-13 (rMMP-13) on collagen gel
contraction by HSFs was also examined. Addition of rMMP-
13 to culture medium enhanced collagen contraction by
HSFs in a dose-dependent manner, the maximal effect noted
with a concentration of 600 ng/ml (Figure 1c and d).
Production of proMMP-1 by dermal fibroblasts in collagen
gel was not altered by rMMP-13 (Figure 1d).
Adenovirally produced MMP-13 is activated by fibroblasts
MMPs are generally secreted as latent zymogens and
activated in the pericellular space (Ravanti and Ka¨ha¨ri,
2000; Sternlicht and Werb, 2001). To investigate whether
proMMP-13 produced by dermal fibroblasts in 3D collagen
after adenoviral infection is activated and exerts collageno-
lytic activity, we used an in vitro assay where MMP-13 was
harvested from the sample media with specific antibody and
incubated with a Europium- (Eu) and quencher-labeled
substrate peptide for MMPs. The substrate peptide was
cleaved with high efficiency in a time-dependent manner,
when incubated with 4-aminophenylmercuric acetate acti-
vated MMP-13 from conditioned medium of RAdMMP-13-
infected HSFs. Also, an increase in Eu signal was detected in
this medium without external activation of MMP-13, indicat-
ing the presence of endogenously activated MMP-13 (Figure
2a). The activated form of MMP-13 in the corresponding
sample medium was also detected by Western immunoblot
analysis (Figure 2b).
To further study the cleavage of fibrillar collagen in 3D
matrix by adenovirally produced MMP-13, HSFs were
infected with RAdMMP-13 or with a control adenovirus
RAdLacZ and cultured in fluorescein-labeled type I collagen
gel for 1–2 days. The gels were fixed, the fibroblasts were
stained for filamentous actin (f-actin) to visualize the cell
shape, and examined with confocal microscopy. After 2 days
of incubation, fluorescent collagen had disappeared around
the MMP-13-expressing fibroblasts, indicating pericellular
collagenolysis by active MMP-13 in RAdMMP-13-infected
fibroblast cultures. In the control adenovirus-infected cul-
tures, the fluorescent collagen was not cleaved in significant
amounts (Figure 2c). This was further verified by measuring
the released fluorescence in cell culture media, which sho-
wed about 20% increase (n¼6, Po0.005, Mann–Whitney
U-test) of fluorescence release in RAdMMP-13-infected
fibroblast cultures. The expression levels of MMP-1 were
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not altered by MMP-13 as detected by Western immunoblot
(data not shown).
MMP-13 inhibitor and expression of TIMP-1 inhibit
MMP-13-enhanced collagen gel contraction by HSFs
To examine whether MMP-13-enhanced contraction of
collagen is related to its actual MMP activity, we infected
HSFs with RAdMMP-13 or with control adenovirus RAdLacZ
and cultured the cells in floating 3D collagen supplemented
with specific MMP-13 inhibitor. MMP-13 inhibitor (2 mM)
reduced MMP-13-enhanced collagen gel contraction po-
tently by 60% (Po0.05), whereas the basal contraction by
RAdLacZ-infected cells was not markedly affected (Figure
3a). The MMP-13 inhibitor did not interfere with cell viability
as detected by nuclear Hoechst staining (data not shown).
Inhibition of MMP-13-enhanced collagen contraction by
inhibitors of MMP-13 activity was further verified by
coinfecting HSFs with adenovirus RAdTIMP-1 for tissue
inhibitor of metalloproteinases-1 (TIMP-1) together with
RAdMMP-13 or with empty control adenovirus RAdpCA3.
MMP-13-enhanced collagen gel contraction was inhibited by
adenoviral coexpression of TIMP-1 (Figure 3b). These results
indicate that MMP-13 possesses enzymatic activity that
augments the contraction process. Transduction of HSFs with
RAdMMP-13 and RAdTIMP-1 resulted in potent expression of
MMP-13 and TIMP-1, respectively, as detected by Western
blot analysis (Figure 3c). The level of endogenous TIMP-1
expression was not altered by MMP-13 inhibitor or by MMP-
13. However, the level of endogenous MMP-1 expression
was not altered by MMP-13 inhibitor but was slightly
downregulated by MMP-13 and TIMP-1 (Figure 3c).
MMP-13 alters actin cytoskeleton and promotes clustering of
f-actin in fibroblasts in 3D collagen
Collagen gel contraction by fibroblasts is dependent on the
functional structure of cellular f-actin, attachment to
surrounding matrix, and to other cells (Cooke et al., 2000;
Ehrlich et al., 2000; Grinnell and Ho, 2002). It is regulated by
various factors, such as transforming growth factor-b,
lysophosphatidic acid and platelet-derived growth factor,
cell number, collagen concentration, and mechanical stress
generated by the surrounding matrix (Grinnell and Ho, 2002;
Tamariz and Grinnell, 2002). Fibroblasts cultured in floating
3D collagen gel acquire a dendritic phenotype in contrast to
myofibroblastic phenotype typical for fibroblasts in mechani-
cally loaded collagen (Grinnell et al., 2003). To examine the
morphology of MMP-13-expressing HSFs in more detail, cells
were cultured for 2 days in floating collagen gel, fixed, and
stained for f-actin with fluorescent-labeled phalloidin. In
accordance with the previous data, control fibroblasts
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Figure 1. Collagenase-3 (MMP-13) enhances collagen gel contraction by HSFs. (a and b) Adult primary HSFs were infected with recombinant adenovirus
RAdMMP-13, encoding human collagenase-3 (MMP-13), or with empty control adenovirus (RAdpCA3) with different MOIs, as indicated, and cultured in
floating 3D type I collagen gel for 4 days in the presence of 0.5% FCS. (c and d) HSFs were cultured in floating 3D type I collagen gel with indicated
concentrations of human recombinant MMP-13 (rMMP-13) added twice: immediately after preparation of the gel and then 48 hours later. A and B represent two
parallel samples. (a and d) The levels of MMP-13 and MMP-1 in the conditioned media were determined by Western immunoblotting. Aliquot of conditioned
medium from RAdMMP-13-infected fibroblasts in (a) was used as positive control for rMMP-13. (b and c) The gels were photographed and the gel areas were
measured using microcomputer imaging device Image Analysis software (n¼ 2).
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showed dendritic morphology with fine and long f-actin
containing projections with few stress fiber-like structures
(Figure 4a). Similarly, few stress fibers were observed in the
presence of MMP-13 (Figure 4b). However, f-actin of MMP-
13-expressing HSFs was organized in numerous brush- or
hair-like structures reaching from cell body to adjacent cells
and surrounding collagen. Compared to actin structures of
control cells, these filaments were clearly shorter and often
very complex in structure (Figure 4b). With higher magnifica-
tion, numerous actin-containing patch-like structures were
also detected along the cell projections of RAdMMP-13-
infected fibroblasts, suggesting altered interaction between
the cells and the surrounding collagen, whereas in control
cells f-actin was evenly distributed at the cortical areas of the
cells (Figure 4c and d). Quantitation of the relative number of
fibroblasts with normal and altered f-actin morphology in
three corresponding experiments showed that the majority of
cells in 3D collagen-expressing MMP-13 displayed altered
f-actin morphology, as compared to RAdLacZ-infected
control cultures (Table 1). Previous studies have shown that
collagen gel contraction by fibroblasts involves collagen
receptor integrins a1b1 and a2b1, as well as Arg-Gly-Asp-
binding integrin aVb3 (Gullberg et al., 1990; Schiro et al.,
1991; Langholz et al., 1995; Cooke et al., 2000). Incubation
with function blocking a2 integrin antibody reduced basal
contraction by control adenovirus-infected fibroblasts by
20%, whereas MMP-13-enhanced collagen gel contraction
was inhibited by up to 40%, indicating that MMP-13-
enhanced contraction is dependent on functional cell
attachment to collagen via a2b1 integrin (data not shown).
The antibody against a1-integrin had no effect on collagen
contraction at the concentration used. The antibody against
aV-integrin had no effect on MMP-13-enhanced contraction,
whereas it partly inhibited basal collagen contraction. The
overall levels of a1 and a2 integrins were relatively low under
both culture conditions and no marked differences were
detected in the expression levels of a1 or a2 integrins at
24–72 hours in cells expressing MMP-13 (data not shown).
MMP-13 promotes survival and proliferation of fibroblasts in
3D collagen
Fibroblasts have been reported to acquire a quiescent
phenotype and undergo apoptosis in floating or mechanically
unloaded collagen gel (Fluck et al., 1998; Rosenfeldt and
Grinnell, 2000; Niland et al., 2001). In this context, we
examined the effect of MMP-13 expression on survival and
proliferation of HSFs in floating 3D collagen gel. In
accordance with the previous observations, numerous
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Figure 2. Determination of catalytic activity of adenovirally produced collagenase-3 (MMP-13). (a) HSFs were infected with recombinant adenovirus
RAdMMP-13, encoding human collagenase-3 (MMP-13), or with control adenovirus (RAdLacZ) encoding E. coli b-galactosidase (LacZ) (250 MOI) and
cultured in floating type I collagen gel for 4 days. MMP-13 was harvested from conditioned media on anti-MMP-13 antibody-coated wells and incubated
with Eu- and quencher-labeled substrate peptide resulting in proteolytic cleavage of peptide by active MMP-13 and induction of Eu signal. In a subset of
samples, MMP-13 was activated with 4-aminophenylmercuric acetate. (b) Active and latent forms of MMP-13 were detected in the conditioned media of
RAdMMP-13-infected fibroblasts cultured in collagen gel by Western immunoblotting. (c) HSFs infected with RAdLacZ and RAdMMP-13 were cultured
for 2 days in FITC-labeled type I collagen gel anchored on cover glass, fixed, and stained with tetramethyl rhodamine isothiocyanate-conjugated phalloidin.
The f-actin in fibroblasts and FITC-labeled collagen at the same location in samples were visualized using confocal microscope at  63 magnification. Two
representative images from collagen gels with RadLacZ- and RAdMMP-13-transduced fibroblasts are shown.
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apoptotic fibroblasts with fragmented DNA and condensed
nuclei were detected with TUNEL and Hoechst staining,
respectively, among uninfected and RAdLacZ-infected con-
trol cells after culturing in collagen for 48 hours (Figure 5a). In
contrast, the RAdMMP-13-infected HSFs showed normal
nuclear morphology and minimal number of apoptotic
TUNEL-positive cells (Figure 5a).
To determine, whether increased survival of MMP-13-
expressing fibroblasts in collagen gel resulted in increased
cell proliferation, we determined DNA synthesis by BrdU
labeling. The results showed that MMP-13 expression also
resulted in increased DNA synthesis of HSFs by over 20%
(Po0.01) (Figure 5b), indicating enhanced cell proliferation
and increased cell number in the gels. There was no
alteration in DNA synthesis when fibroblasts correspondingly
infected with control adenovirus or with RAdMMP-13 were
cultured in monolayer on plastic cell culture wells (data not
shown).
To further study the mechanism of enhanced cell survival
and proliferation by MMP-13, we analyzed phosphorylation
of Akt, extracellular signal-regulated kinase1/2 (ERK1/2), and
p38, signal molecules involved in the regulation of cell
survival and proliferation (Franke et al., 1997; Chang and
Karin, 2001). Immunoblot analysis of cell lysates of MMP-13-
expressing HSFs showed marked increase in the levels of
phosphorylated (serine 473) Akt, indicating activation of PI3K
pathway enhancing cell survival in 3D collagen (Figure 5c).
In addition, expression of MMP-13 resulted in phosphoryla-
tion and activation of ERK1/2, associated with increased cell
proliferation. In contrast, phosphorylation of p38 MAPK was
unaltered (Figure 5c).
DISCUSSION
Fibroblast-mediated contraction of collagenous ECM is an
important phase of normal wound healing in adult skin, and it
accelerates wound closure by bringing wound edges closer to
each other (Tomasek et al., 2002). Furthermore, contraction
contributes to remodeling of newly formed collagenous
dermal matrix, in which collagen molecules secreted by
fibroblasts are assembled into fibrils and oriented in a
direction that provides sufficient tensile strength to skin
(Prockop and Kivirikko, 1995; Tomasek et al., 2002).
Collagen remodeling by fibroblasts is regulated by various
factors such as fibroblast–myofibroblast transformation
(Tomasek et al., 2002), transforming growth factor-b, plate-
let-derived growth factor, lysophosphatidic acid, mechanical
stimulus by the surrounding matrix as well as by cell number
in collagen (Grinnell and Ho, 2002; Tamariz and Grinnell,
2002). There is plenty of evidence indicating that collagen
remodeling is also dependent on the function of MMPs. This
is demonstrated in vitro and in vivo using wide-spectrum
chemical MMP inhibitors, which reduced fibroblast-
mediated collagen contraction and wound contraction (Scott
et al., 1998; Phillips et al., 2003; Mirastschijski et al., 2004).
In addition, mice lacking MMP-3 show reduced wound
contraction (Bullard et al., 1999) and mice with targeted
mutation in collagenase cleavage site in mouse type I
collagen a1 chain display impaired contraction and
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Figure 3. MMP-13 inhibitor and expression of TIMP-1 inhibit MMP-13-enhanced collagen gel contraction by HSFs. (a) HSFs were infected with recombinant
adenovirus RAdMMP-13 or with control adenovirus (RAdLacZ) encoding E. coli b-galactosidase (LacZ) (150 MOI) and cultured in floating contractile collagen
gel in the presence of 0.5% FCS and in the presence or absence of 2 mM MMP-13 inhibitor pyrimidine-4,6-dicarboxylic acid, bis-(4-fluoro-3-methyl-
benzylamide). After 2 days of incubation, the gels were photographed and the gel areas were quantified using microcomputer imaging device Image Analysis
software (n¼ 4). Statistical significance was determined by Mann–Whitney U-test: *Po0.05; a, compared to RAdLacZ control; b, compared to RAdMMP-13
control. (b) HSFs were infected with RAdMMP-13 or with empty control adenovirus (RAdpCA3) at MOI 125 and coinfected with adenovirus coding for TIMP-1
(RAdTIMP-1) at MOI 500. Cells were then cultured in floating contractile collagen gel in the presence of 0.5% FCS for 4 days. The gels were photographed and
the gel areas were quantified as above (n¼2). (c) The levels of MMP-13, MMP-1, and TIMP-1 in the conditioned media were determined by Western
immunoblotting.
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re-epithelialization of the skin wounds (Beare et al., 2003).
Furthermore, reports showing elevated levels of several
MMPs relative to TIMP expression in scarless healing of
wounds in fetal mouse skin (Dang et al., 2003) and increased
activation of MMP-2 and collagen gel contraction by oral
fibroblasts (Stephens et al., 2001) emphasize the role of
MMPs in efficient collagen remodeling.
We have previously noted that human fetal skin fibroblasts
express MMP-13 during wound healing (Ravanti et al., 2001),
and that MMP-13 is also expressed by fibroblasts during
wound repair in adult human gingiva (Ravanti et al., 1999b).
Both types of wounds are characterized by rapid closure,
efficient remodeling of newly formed collagenous dermis,
and scarless healing. In addition, the expression of MMP-13
by human gingival and fetal skin fibroblasts is potently
upregulated by transforming growth factor-b, whereas adult
HSFs normally express MMP-13 at low level only when
cultured within 3D collagen (Ravanti et al., 1999a, b, 2001).
In the present study, we noted that primary adult HSFs
expressing high levels of MMP-13, as a result of adenoviral
MMP-13 gene delivery, remodel collagen matrix with high
efficiency demonstrated by potent collagen gel contraction.
Increased collagen gel remodeling was also noted after
addition of rMMP-13 to the culture medium of fibroblasts.
However, collagen gel remodeling induced by rMMP-13 was
not as potent as that achieved by adenovirally produced
MMP-13. It is hypothesized that MMP-13 enhances collagen
contraction primarily and ultimately by partial cleavage of
collagen fibers, although it is possible that other mechanisms,
for example, activation of other factors, may be involved. Our
results show that restricted collagenolysis by adenovirally
expressed MMP-13 takes place in the proximity of the cell. It
is therefore possible that exogenously added latent rMMP-13
is not distributed in high enough concentration to the
pericellular areas to be activated and cleave collagen as
potently as MMP-13 produced by the fibroblasts.
It has been well documented that fibroblasts cultured in
mechanically non-stressed, freely floating collagen gel do not
acquire myofibroblastic phenotype characterized by expres-
sion of a-smooth muscle actin and stress fibers, but they
exhibit dendritic morphology with long and thin cell
protrusions (Grinnell et al., 2003). Several studies have
shown that these fibroblasts are still able to promote collagen
remodeling, resulting in collagen gel contraction (Grinnell,
1994). In the present study, staining of HSFs in fluorescent-
labeled collagen attached on cover glasses for f-actin
revealed numerous stress fibers generated by mechanically
loaded matrix. In accordance with the previous observations
RAdLacZ RAdMMP-13
a b
c d
Figure 4. Expression of collagenase-3 (MMP-13) alters morphology and
promotes clustering of f-actin in fibroblasts in 3D collagen. HSFs were
infected with recombinant adenovirus RAdMMP-13, encoding human
collagenase-3 (MMP-13), or with control adenovirus (RAdLacZ) encoding
E. coli b-galactosidase (LacZ) (250 MOI) and cultured in floating type I
collagen gel for 2 days in the presence of 0.5% FCS. The gels were fixed with
paraformaldehyde and fibroblasts were stained with tetramethyl rhodamine
isothiocyanate-conjugated phalloidin. The staining of f-actin was detected
using confocal microscope at (a and b) 40 and (scan zoom: 2 c and d)  63
magnification. The arrows in (a and b) identify fibroblast protrusions in
collagen gel and arrowheads in (c and d) indicate actin-rich areas at higher
magnification. Bar¼ 20 mm.
Table 1. Quantitation of HSFs with normal and altered f-actin morphology in 3D collagen1
RadLacZ RAdMMP-13
N
Cells with normal
f-actin morphology2
Cells with altered
f-actin morphology3
Cells with normal
f-actin morphology2
Cells with altered
f-actin morphology3
Exp 1 128 78.2 3.6 8.2 72.6
Exp 2 23 83.3 0 0 90.9
Exp 3 197 63.5 4.8 6.5 60.2
3D, three dimensional; Exp, experiment; f-actin, filamentous actin; HSFs human skin fibroblasts; RAdMMP-13, adenovirus encoding human MMP-13.
1HSFs were treated as in Figure 4. Two (experiments 2 and 3) and four (experiment 1) image stacks from cells at different sites in a collagen gel were
generated using confocal microscope. Individual cells were counted and divided into three groups based on their f-actin morphology. The results are
presented in percentage value of all counted cells in one collagen gel.
2Fibroblasts with several thin and relatively long f-actin extensions.
3Fibroblasts with generally short, hair- and bunch-like f-actin extensions with patchy f-actin distribution.
The third group contained the fibroblasts that could be included in neither group described above (e.g. round cells).
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(Grinnell, 1994), no obvious stress fibers were detected in
fibroblasts cultured in floating collagen gel. However, f-actin
staining of HSFs expressing MMP-13 revealed that the
extensions of these cells were generally shorter and
structurally more complex than in control fibroblasts,
possibly owing to exposure of cryptic binding sites from
collagen by MMP-13 for cell adhesion and active retraction
of the extended protrusions.
Interestingly, f-actin of the control fibroblasts cultured in
3D gel was evenly distributed in the dendritic cell protru-
sions, whereas f-actin of MMP-13-expressing HSFs was
condensed to patch-like structures located along the cell
extensions, suggesting altered cell contact to surrounding
collagen cleaved by MMP-13. Resembling these structures,
fibroblasts cultured on a rigid substrate generate focal
adhesion sites, in which integrins are clustered on cell
membrane together with cellular signaling proteins and
cytoskeletal components to integrate intracellular compart-
ment with ECM (Petit and Thiery, 2000). However, when
fibroblasts are cultured in mechanically unloaded matrix (e.g.
floating collagen gel), the large focal adhesions are absent,
and focal adhesion complex proteins, focal adhesion kinase
(FAK), talin, paxillin, and p130cas are downregulated (Wang
et al., 2003). It remains to be elucidated whether the actin-
containing clusters detected at the cell extensions of MMP-
13-expressing HSFs can be distinguished as focal adhesions.
However, these structures were detected already after
culturing HSFs in collagen gel for 2 days, when the degree
of collagen contraction was not yet very extensive, making it
unlikely that focal adhesions were formed as a result of
increased rigidity of the strongly remodeled collagen.
Furthermore, the cell surface levels of collagen receptor
integrins a1b1 and a2b1, which mediate collagen contraction
and are recruited to focal adhesion sites (Schiro et al., 1991;
Ivaska et al., 1999), were not altered by MMP-13 expression
of HSFs cultured in floating 3D collagen.
A number of studies have demonstrated that fibroblasts in
floating or in attached and released collagen gels acquire
quiescence involving disruption in ERK signaling (Rosenfeldt
and Grinnell, 2000; Fringer and Grinnell, 2003) and
subsequent apoptosis (Fluck et al., 1998; Niland et al.,
2001; Tian et al., 2002; Xia et al., 2004). Cell surface
integrins function as mechanoreceptors for cells in 3D
collagen, and focal adhesion kinase and Akt are phosphory-
lated as a result of collagen ligation with b1 integrin (Carlson
et al., 2004; Xia et al., 2004). However, during contraction of
collagen gel, a2b1 integrin appears to serve as a receptor for
alterations in mechanical stimulus generated by surrounding
collagen and it initiates a signaling cascade leading to
dephosphorylation of Akt and subsequent apoptosis (Ivaska
et al., 2002; Tian et al., 2002; Carlson et al., 2004; Xia et al.,
2004). This process may also involve activation of the
function of p53 (Carlson et al., 2004). In contrast to a2b1
integrin, aV-integrin, which binds to Arg-Gly-Asp motif in
denatured collagen, has been shown to promote survival of
melanoma cells in 3D collagen via inactivation of p53 and
activation of MEK1 and ERK1/2 pathway (Bao and Stro¨mblad,
2004).
Here, we show that adenoviral expression of human
MMP-13 by HSFs promotes their escape from cell quiescence
and apoptosis induced by contractile floating collagen gel,
and despite simultaneous enhancement of collagen gel
contraction increases their survival and proliferation. This is
expected to result in increased number of HSFs in 3D
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Figure 5. Expression of collagenase-3 (MMP-13) promotes survival and
proliferation of HSFs in 3D collagen. HSFs were infected with recombinant
adenovirus RAdMMP-13, encoding human collagenase-3 (MMP-13), or
with control adenovirus (RAdLacZ) encoding E. coli b-galactosidase (LacZ)
(MOI 125) or left uninfected, and cultured in floating type I collagen gel.
(a) After culturing for 48 hours, the gels were fixed with paraformaldehyde
and stained with TUNEL and Hoechst 33258 to detect apoptotic cells. The
figure shows TUNEL (left) and Hoechst staining (right) at the same location in
the collagen gel sample. The average proportion of apoptotic nuclei 7SD
are presented on the right (uninfected: n¼38, n¼38; RAdLacZ: n¼45,
n¼ 37; RAdMMP-13: n¼ 36, n¼ 36, n¼45). (b) To quantify DNA synthesis,
BrdU was added in culture media 24 hours after seeding fibroblasts in
collagen gel, and cultures were incubated for 24 hours. Fibroblasts were
released from gels by treatment with bacterial collagenase and analyzed for
incorporation of BrdU into DNA using colorimetric immunoassay. Data
represent mean7SD. Statistical significance was determined using Man-
n–Whitney test (n¼ 5). (c) Fibroblasts were harvested from collagen gels at
indicated time points, as in (b), and cell lysates were analyzed for the levels of
phospho-Akt (p-Akt), phospho-ERK1/2 (p-ERK1/2), and phospho-p38 (p-p38),
and total Akt, ERK1/2, p38, and b-actin with Western immunoblotting.
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collagen, and efficiently augment collective collagen gel
contraction. We detected a potent phosphorylation of Akt in
HSFs expressing MMP-13, suggesting disrupted signaling via
mechanoreceptor a2b1-integrin. This could be owing to a
shift of collagen ligation via a2b1-integrin to aV-integrin, or
altered out-side-in signaling initiated by reduced affinity of
a2b1 to cleaved and denatured type I collagen. In accor-
dance with increased proliferative activity, we also observed
activation of ERK1/2 in HSFs expressing human MMP-13.
ERK1/2 signaling pathway can be influenced by cell
adhesion, cell shape, and cytoskeletal organization (Huang
and Ingber, 1999).
To conclude, our results demonstrate a multifunctional
role for human MMP-13 in remodeling of collagenous ECM,
an important process in normal acute wound healing. Our
results show that MMP-13 expression potently enhances
collagen gel contraction by adult skin fibroblasts in a cell
culture model, which mimics dermal compartment of skin.
We also detected various phenotypic chances in these
fibroblasts providing mechanisms how human MMP-13
promotes matrix remodeling. We provide evidence showing
that MMP-13-mediated collagenolysis promotes escape of
fibroblasts from cell quiescence and apoptosis normally
induced by floating and contractile collagen gel. This may be
an important survival mechanism for dermal fibroblasts
embedded in fibrotic collagen in chronic dermal ulcers
(Vaalamo et al., 1997). Finally, our results suggest that human
MMP-13 may also enhance wound contraction in vivo and
promote scarless healing of adult gingival and fetal skin
wounds by enhancing matrix remodeling.
MATERIALS AND METHODS
Cell cultures and reagents
Primary adult HSFs were established from a skin punch biopsy
obtained from the arm of a healthy male volunteer (age 27 years). All
studies were approved by the ethical committee of the University of
Turku. Participants gave their written informed consent, and the
study was conducted according to the Declaration of Helsinki
Principles. HSFs were cultured in DMEM (Flow Laboratories, Irvine,
UK) supplemented with 10% fetal calf serum (FCS), 2 mM
L-glutamine, 100 IU/ml penicillin G, and 100 mg/ml streptomycin.
HSFs were used between passages 6 and 15. MMP-13 inhibitor
pyrimidine-4,6-dicarboxylic acid, bis-(4-fluoro-3-methyl-benzyla-
mide) was purchased from Calbiochem (Merck Biosciences,
Darmstadt, Germany). Function blocking antibodies against a1-
and a2-integrins (SR-84 and AK-7, respectively) were purchased
from BD Biosciences Pharmingen (San Diego, CA). Hybridoma cell
line producing function blocking mAb L230 against aV-integrin was
obtained from ATCC (Manassus, VA). The FITC-conjugated type I
collagen from bovine skin (D-12060) was obtained from Molecular
Probes Inc. (Eugene, OR).
Production of rMMP-13
The recombinant baculovirus for human proMMP-13 was generated
using the Bac-To-Bac baculovirus expression system (GIBCO BRL,
Gaithersburg, MD). To produce the recombinant pFastBAC1 donor
plasmid, the region corresponding to nucleotides 10–1,429 of MMP-
13 cDNA, originally derived from TNF-a-treated human SCC cells
(Ala-aho et al., 2002), in pCI-neo vector was amplified using PCR by
simultaneously introducing NheI and SpeI sites at the 50 and 30 ends,
correspondingly. Tev protease consensus sequence (ENLYFQS) and
the myc tag sequence (EQKLISEEDL) were introduced to the 30 SpeI
site by primer annealing and ligation proceeded by T4 kinase
treatment of the primers. The sequence was verified by sequencing.
The recombinant baculovirus was generated according to the
manufacturer’s instructions. For production of proMMP-13, recom-
binant baculovirus was added in Sf9 cell cultures (ATCC CRL 1711)
in SF-900 II SFM serum-free culture medium (GIBCO BRL),
supplemented with 0.5 PSN antibiotic mixture (GIBCO BRL) for
3 days at 271C in a shaker at 125 r.p.m. The cells were pelleted by
centrifugation (1,000 g, 5 minutes) and the supernatant was
analyzed by Western blotting for proMMP-13 production using
myc and MMP-13-specific antibodies. Catalytic activity of MMP-13
was analyzed by radioactive collagen cleavage assay following
activation by ammonium polymethacrylate (Ala-aho et al., 2002).
The concentration of MMP-13 in the supernatant was determined
using BiotrakTM ELISA system according to the manufacturer’s
instructions (Amersham Pharmacia Biotech, UK).
Adenoviral infection of primary skin fibroblasts
Recombinant replication-deficient adenovirus RAdLacZ (Wilkinson
and Akrigg, 1992), which contains the E. coli b-galactosidase (lacZ)
gene under the regulation of the cytomegalovirus immediate early
(CMV IE) promoter has been described previously (Wilkinson and
Akrigg, 1992). The construction of control adenovirus RAdpCA3 and
recombinant adenoviruses for human MMP-13 (RAdMMP-13) and
TIMP-1 (RAdTIMP-1) has been described previously (Wilkinson and
Akrigg, 1992; Baker et al., 1996; Ala-aho et al., 2002; Leivonen
et al., 2002). HSFs were infected in suspension with adenoviruses at
multiplicity of infection (MOI) 50–500 for 16 hours in the presence of
0.5% FCS. Thereafter, culture medium was replaced with fresh
DMEM containing 0.5% FCS and HSFs were incubated for an
additional 24 hours, detached with trypsin, and suspended into
collagen gel.
Construction of 3D collagen gels and analysis of collagen gel
contraction
3D collagen gels were prepared from native bovine dermal collagen
containing 95% type I collagen and 5% type III collagen (Cellon,
Strassen, France) as described previously (Ravanti et al., 1999a).
Briefly, acid-soluble Cellon was neutralized by mixing 8 volumes of
Cellon with 1 volume of 10 concentrated DMEM and 1 volume of
NaOH in 0.2 M HEPES buffer (pH 7.4) to obtain a final collagen
concentration of 2.4 mg/ml. To examine the effect of MMP-13 and
TIMP-1 expression on collagen gel remodeling by HSFs, uninfected
or adenovirus-infected fibroblasts (5 105) were trypsinized and re-
suspended into 600 ml of neutralized Cellon gel, suspension was cast
on pre-solidified Cellon in 24-well plates, and incubated at 371C for
collagen polymerization. Thereafter, the gels were detached from
the wells and 600ml of 0.5% FCS DMEM was added. In certain
experiments, recombinant human proMMP-13 was added to the
medium twice: immediately after collagen gel preparation and
48 hours later. A chemical inhibitor of MMP-13 or vehicle was
added to 3D cell cultures simultaneously with medium in 2mM concen-
tration. In experiments with function-blocking antibodies against
a2- and a1-integrins, 1mg of either antibody was administered to cell
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suspension before addition of collagen and 2mg of antibody was
added simultaneously with culture medium in final concentration
5mg/ml. For aV-integrin, 5 mg of antibody was added to cell
suspension before collagen addition and 10 mg simultaneously with
culture medium to get the final concentration of 25 mg/ml. Collagen
gel contraction by HSFs was observed for 1–4 days, the gels were
photographed and their areas were measured using microcomputer
imaging device Image Analysis software (Imaging Research Inc., St
Catharines, Ontario, Canada).
Analysis of collagenolytic activity
Proteolytic activity of MMP-13 in the conditioned media of HSFs
cultured in 3D collagen was analyzed in vitro. Briefly, equal aliquots
of conditioned media were incubated in the 96-well plate coated
with anti-MMP-13 antibody (clone 181-15A12; Calbiochem, San
Diego, CA). After extensive washing, the specifically bound MMP-13
was incubated at room temperature with Eu- and quencher-labeled
peptide containing a cleavage site for MMPs. In a subset of samples,
MMP-13 was activated with 1 mM 4-aminophenylmercuric acetate
for 30 minutes in 371C. The time-resolved Eu signal produced by
peptide cleavage was detected with Victor2TM 1423 Multilabel
Counter (Perkin-Elmer Life and Analytical Sciences, Wallac Finland
OY, Turku, Finland).
To detect the collagenolytic activity in situ in cell cultures in 3D
collagen, RAdLacZ-, and RAdMMP-13-infected fibroblasts were
seeded in type I collagen gel containing 3% of fluorescein-
conjugated collagen, cast on sterile cover glasses, and cultured for
2 days anchored on glass in the presence of DMEM containing 0.5%
FCS. The gels were then fixed with 4% paraformaldehyde at 371C
overnight, and degradation of fluorescein-conjugated collagen from
the pericellular areas was detected with Zeiss LSM 510 confocal
microscope. Released fluorescence (485/535 nm) in the cell culture
media was quantified using Victor2TM 1423 Multilabel Counter
(Perkin-Elmer Life and Analytical Sciences, Wallac Finland OY,
Turku, Finland).
Staining of f-actin and detection of apoptotic cells
The fibroblast-containing collagen gels were washed with phos-
phate-buffered saline at 371C and fixed with 4% paraformaldehyde
at 371C overnight. The gels were permeabilized with 1% Triton
X-100 in phosphate-buffered saline. For actin staining, the gels were
washed and incubated with tetramethyl rhodamine isothiocyanate-
conjugated phalloidin (P-1951, Sigma Chemical Co., St Louis, MO)
at concentration 1mg/ml overnight at 41C. After washing with
phosphate-buffered saline, the gels were mounted on object glasses
with Mowiol solution and examined and photographed with the
Zeiss LSM 510 confocal microscope. To detect the apoptotic cells,
the permeabilized cells were stained with Hoechst 33258 and with
TUNEL kit (Roche, Mannheim, Germany) according to the manu-
facturer’s instructions, mounted on object glasses, and visualized
with fluorescence microscope.
Immunoblot analysis
HSFs were released from collagen by short treatment with bacterial
collagenase (type II; Sigma Chemical Co., St Louis, MO) 0.2 mg/ml
in phosphate-buffered saline (pH 7.4) containing 1 mM CaCl2,
pelleted, and lysed with SDS sample buffer. Equal aliquots of cell
culture media or cell lysates were fractionated electrophoretically in
SDS-PAGE and transferred to nitrocellulose membranes. To detect
the human MMP-13 and MMP-1 in the media by immunoblotting,
mouse mAb against human MMP-13 (181-15A12; Calbiochem, San
Diego, CA) and rabbit polyclonal antibody against MMP-1 (AB806;
Chemicon International Inc., Temecula, CA) at 0.2 mg/ml concentra-
tions were used. To determine the levels of TIMP-1 in the medium,
aliquots of conditioned media were reduced with 5% b-mercap-
toethanol before electrophoretic fractionation and analyzed by
Western blotting with rabbit polyclonal antibody (AB800, 0.2mg/
ml) (Chemicon International Inc., Temecula, CA). For analyzing cell
lysates, polyclonal antibody against b-actin (A1978) was purchased
from Sigma Chemical Co (St Louis, MO), and for phospho-ERK1/2,
ERK1/2, phospho-p38, p38, and phospho-Akt (Ser473) from Cell
Signaling Technology (Beverly, MA). Anti-Akt antibody was pur-
chased from Santa Cruz Biotechnology Inc. (sc-1618, Santa Cruz,
CA). The specific binding of primary antibodies was detected with
peroxidase-conjugated secondary antibodies and visualized by
enhanced chemiluminescence (Amersham Biosciences).
Analysis of DNA synthesis
DNA synthesis was measured with colorimetric immunoassay
quantifying the incorporation of BrdU into DNA according to the
manufacturer’s instructions (Roche, Mannheim, Germany). BrdU
was added in culture media 24 hours after casting fibroblasts in
collagen gel or when cultured in monolayer on plastic cell culture
wells, 24 hours after infection, and incubated for 24 hours. For
analysis, the fibroblasts were released from gels with bacterial
collagenase treatment as described above.
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